论文部分内容阅读
目的探讨阿奇霉素联合甲泼尼龙辅助治疗小儿难治性支原体肺炎的临床疗效。方法选取横县人民医院儿科2014年1月—2016年1月收治的难治性支原体肺炎患儿40例,按照患儿入院时间不同分为对照组与试验组,各20例。对照组予以阿奇霉素治疗,试验组患儿在对照组基础上予以甲泼尼龙治疗,比较两组患儿临床疗效、临床体征改善时间(胸部X线检查恢复正常时间、肺部啰音消失时间、咳嗽减轻时间和退热时间)。结果试验组患儿临床疗效优于对照组(P<0.05)。试验组患儿胸部X线检查恢复正常时间、肺部啰音消失时间、咳嗽减轻时间和退热时间短于对照组(P<0.05)。结论阿奇霉素联合甲泼尼龙正常辅助治疗小儿难治性支原体肺炎的临床疗效确切,利于改善患儿临床症状,缩短治疗时间。
Objective To investigate the clinical efficacy of azithromycin combined with methylprednisolone in the treatment of refractory mycoplasma pneumonia in children. Methods Forty children with refractory mycoplasma pneumonia who were treated in Hengxian People’s Hospital from January 2014 to January 2016 were selected and divided into control group and trial group according to their admission time. The control group was treated with azithromycin. The children in the experimental group were treated with methylprednisolone on the basis of the control group. The clinical curative effect, clinical signs and improvement time (chest X-ray examination recovery time, pulmonary rales disappearance time, cough Reduce time and antipyretic time). Results The clinical efficacy of the experimental group was better than that of the control group (P <0.05). The chest X-ray examination in the experimental group returned to normal time, the pulmonary rales disappeared time, cough relief time and antipyretic time shorter than the control group (P <0.05). Conclusion Azithromycin combined with methylprednisolone adjuvant treatment of infantile refractory mycoplasma pneumonia clinical curative effect is exact, which will help to improve children’s clinical symptoms and shorten the treatment time.